Kos to consolidate process operations
Kos Pharmaceuticals will consolidate manufacturing operations for its Niaspan product and for its new Niaspan/Lovastatin combination product, Advicor, within its larger, more efficient manufacturing facility in Edison, NJ, US. Simultaneously, the company's current Niaspan manufacturing site in Hollywood, FL, US, will be converted to a dedicated development and scale-up facility for the solid-dose products the company produces.